Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Nice investment (Not) Loss--$372,325

If accurate, that valuation represents only a 3% haircut on the ARS value. I'd take that in a heartbeat.

The ARS issue, while annoying, is small potatoes, imho, and blame should be assigned to the broker(s) who sold them to PTSC and their employer who then abandoned the market.

Share
New Message
Please login to post a reply